Microbion to Present New Data Demonstrating that Pravibismane Disrupts Bacterial Bioenergetics at ASM Microbe 2023

Pravibismane is the first of a new class of drugs with broad-spectrum potency against a wide range of pathogens Poster presentation will highlight the results of a gene knockdown study suggesting pravibismane’s mechanism of action impacts bacterial bioenergetics and fatty acid…

About the Author

has written 21803 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com